Silodosin Pensa 8 mg hard capsules EFG
Spain
Table of Contents
Package leaflet: Information for the user
Introduction
Package leaflet: information for the patient
Silodosin Pensa 8 mg hard capsules EFG
silodosin
Read the entire leaflet carefully before you start taking this medicine, as it contains important information for you.
- Keep this leaflet as you may need to read it again.
- If you have any questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only, and you should not give it to others, even if they have the same symptoms as you, because it may harm them.
- If you experience any adverse effects, consult your doctor or pharmacist, even if they are adverse effects not listed in this leaflet. See section 4.
Leaflet contents:
- What Silodosin Pensa is and what it is used for
- What you need to know before taking Silodosin Pensa
- How to take Silodosin Pensa
- Possible side effects
- How to store Silodosin Pensa
- Contents of the pack and other information
1. What Silodosin Pensa is and what it is used for
What silodosin is
Silodosin belongs to a group of medicines called alpha1A-adrenergic receptor blockers.
Silodosin is selective for receptors located in the prostate, bladder, and urethra. By blocking these receptors, it causes relaxation of the smooth muscle in these tissues. This makes it easier for you to urinate and relieves your symptoms.
What silodosin is used for
Silodosin is used in adult men to treat urinary symptoms associated with benign enlargement of the prostate (benign prostatic hyperplasia, BPH), such as:
- difficulty starting urination
- feeling of not completely emptying the bladder
- need to urinate more frequently, even at night
2. What you need to know before taking Silodosin Pensa
Do not take silodosin
If you are allergic to silodosin or to any of the other ingredients of this medicine (listed in section 6).
Warnings and precautions
Consult your doctor or pharmacist before taking this medicine:
-
If you are scheduled for eye surgery due to clouding of the lens (cataract surgery), it is important that you immediately inform your ophthalmologist that you are currently taking or have previously taken silodosin. This is because some patients treated with this type of medication have experienced a loss of muscle tone in the iris (the colored circular part of the eye) during this type of surgery. The ophthalmologist can then take appropriate precautions regarding the medical and surgical techniques to be used. Ask your doctor whether it is necessary to delay or temporarily interrupt treatment with silodosin prior to undergoing cataract surgery.
-
If you have ever fainted or felt dizzy upon standing up suddenly, inform your doctor before taking silodosin.
When taking silodosin, dizziness and, occasionally, fainting may occur upon standing, especially when starting treatment or if you are taking other medications that lower blood pressure. If this occurs, sit or lie down immediately until symptoms resolve and inform your doctor as soon as possible (see also section “Driving and use of machines”).
-
If you have severe liver problems, you should not take silodosin, as it has not been evaluated in this condition.
-
If you have kidney problems, consult your doctor.
If your kidney problems are moderate, your doctor will initiate treatment with silodosin cautiously and possibly at a lower dose (see section 3 “Dosage”). If your kidney problems are severe, you should not take this medicine.
-
Since benign enlargement of the prostate and prostate cancer can cause the same symptoms, your doctor will examine you to rule out prostate cancer before starting treatment with silodosin. Silodosin is not effective for treating prostate cancer.
-
Treatment with this medicine may lead to abnormal ejaculation (reduced amount of semen ejaculated during sexual intercourse), which may temporarily affect male fertility. This effect resolves after discontinuation of silodosin. Inform your doctor if you are planning to have children.
Children and adolescents
Do not administer this medicine to children and adolescents under 18 years of age, as there are no relevant indications for this age group.
Taking silodosin with other medicines
Inform your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicines.
In particular, inform your doctor if you are taking:
- Medicines that lower blood pressure (especially alpha1-blockers such as prazosin or doxazosin), as there may be a potential risk that the effect of these medicines increases during treatment with silodosin.
- Antifungal medicines (such as ketoconazole or itraconazole), medicines used for HIV/AIDS infection (such as ritonavir), or medicines used after organ transplantation to prevent organ rejection (such as cyclosporine), as these medicines may increase blood levels of silodosin.
- Medicines used to treat erectile dysfunction (such as sildenafil or tadalafil), as concomitant use with silodosin may lead to a slight decrease in blood pressure.
- Medicines for epilepsy or rifampicin (a medicine used to treat tuberculosis), as the effect of silodosin may be reduced.
Driving and use of machines
Do not drive or operate machinery if you experience weakness, dizziness, drowsiness, or blurred vision.
3. How to take/use Silodosin Pensa
Follow exactly the administration instructions for this medicine given by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
The recommended dose is one 8 mg silodosin capsule per day, taken orally.
Take the capsule always with food, preferably at the same time each day. Do not break or chew the capsule; swallow it whole, preferably with a glass of water.
Patients with kidney problems
If you have moderate kidney problems, your doctor may prescribe you a different dose. For this purpose, the 4 mg silodosin hard capsule formulation is available.
If you take more silodosin than you should
In case of overdose or accidental ingestion, contact your doctor or pharmacist immediately or call the Toxicology Information Service at telephone: 91 562 04 20, indicating the medicine and the amount ingested. If you feel dizzy or weak, inform your doctor immediately.
If you forget to take silodosin
You may take the capsule later the same day if you forgot to take it earlier. If it is almost time for your next dose, do not take the missed dose. Do not take a double dose to make up for the forgotten capsule.
If you stop taking silodosin
If you stop treatment, your symptoms may return.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
4. Possible adverse effects
Like all medicines, this medicine can cause adverse effects, although not everyone will experience them.
Contact your doctor immediately if you experience any of the following allergic reactions, as they could have serious consequences: swelling of the face or throat, difficulty breathing, feeling faint, skin itching, or hives.
The most common adverse effect is a reduction in the amount of semen ejaculated during sexual intercourse. This effect disappears after stopping treatment with silodosin. Inform your doctor if you are planning to have children.
Dizziness, including dizziness upon standing, and occasionally fainting, may occur.
If you feel weak or dizzy, sit or lie down immediately until symptoms subside. If you experience dizziness upon standing or fainting, inform your doctor as soon as possible.
Silodosin may cause complications during cataract surgery (eye surgery for lens clouding; see section “Warnings and precautions”).
It is important that you inform your ophthalmologist immediately if you are currently taking or have previously taken silodosin.
The possible adverse effects are listed below:
Very common adverse effects (may affect more than 1 in 10 people)
- Abnormal ejaculation (a reduced or negligible amount of semen is ejaculated during sexual intercourse; see section “Warnings and precautions”)
Common adverse effects (may affect up to 1 in 10 people)
- Dizziness, including dizziness upon standing (see also above in this section)
- Nasal discharge or nasal congestion
- Diarrhea
Uncommon adverse effects (may affect up to 1 in 100 people)
- Loss of sexual appetite
- Nausea
- Dry mouth
- Difficulty achieving or maintaining an erection
- Increased heart rate
- Skin allergic reactions such as rash, pruritus, urticaria, and drug-induced rash
- Abnormal liver function test results
- Low blood pressure
Rare adverse effects (may affect up to 1 in 1,000 people)
- Rapid or irregular heartbeat (known as palpitations)
- Fainting/loss of consciousness
Very rare adverse effects (may affect up to 1 in 10,000 people)
- Other allergic reactions with swelling of the face or throat
Frequency not known (frequency cannot be estimated from available data)
- Floppy iris during cataract surgery (see also above in this section)
Inform your doctor if you notice any changes in your sexual activity.
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this leaflet. You may also report them directly via the Spanish Pharmacovigilance System for Human Medicines: https://www.notificaram.es. By reporting adverse effects, you can help provide more information on the safety of this medicine.
5. Storage of Silodosin Pensa
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton and blister after "EXP". The expiry date refers to the last day of the month indicated.
Do not store above 30°C.
Keep the blister in the cardboard carton to protect the medicine from light.
Do not use this medicine if you notice that the packaging is damaged.
Medicines should not be disposed of via wastewater or household waste. Dispose of unused medicines and their packaging at the SIGRE Point at your pharmacy. If in doubt, ask your pharmacist how to dispose of unused medicines and packaging. This will help protect the environment.
6. Contents of the pack and other information
Composition of Silodosina Pensa
-
The active substance is silodosin. Each capsule contains 8 mg of silodosin.
-
The other components are mannitol (E421), pregelatinized corn starch, sodium lauryl sulfate, magnesium stearate, gelatin, titanium dioxide (E171).
-
Printing ink: shellac, black iron oxide (E172), potassium hydroxide.
Appearance of the product and contents of the pack
Hard gelatin capsule, white, size 0, marked with “S” on the cap and “8” on the body.
Silodosina Pensa is available in packs of 30, 50, and 100 capsules. Only certain pack sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Towa Pharmaceutical, S.A.
C/ de Sant Martí, 75-97
08107 Martorelles (Barcelona)
Spain
Manufacturer
NOUCOR HEALTH, S.A.
Av. Camí Reial, 51-57
08184 – Palau-solità i Plegamans
(Barcelona-Spain)
This medicinal product is authorized in the Member States of the European Economic Area under the following names:
Spain: Silodosina Pensa 8 mg hard capsules EFG
Italy: Silodosina Pensa
Date of the most recent review of this product information: January 2019
Detailed and up-to-date information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es